These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


251 related items for PubMed ID: 7201845

  • 1. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
    Hirst DG, Brown JM, Hazlehurst JL.
    Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
    [Abstract] [Full Text] [Related]

  • 2. Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Hirst DG, Brown JM, Hazlehurst JL.
    Cancer Res; 1983 May; 43(5):1961-5. PubMed ID: 6682009
    [Abstract] [Full Text] [Related]

  • 3. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
    Lee FY, Workman P.
    Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
    [Abstract] [Full Text] [Related]

  • 4. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
    Siemann DW.
    Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT.
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [Abstract] [Full Text] [Related]

  • 11. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT, Siemann DW.
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
    Mulcahy RT, Dembs NL, Ublacker GA.
    Br J Cancer; 1984 Mar; 49(3):307-13. PubMed ID: 6704305
    [Abstract] [Full Text] [Related]

  • 13. Cross-link formation and chemopotentiation of EMT-6/Ro cells exposed to MISO after CCNU treatment in vitro.
    Mulcahy RT.
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1389-92. PubMed ID: 3759561
    [Abstract] [Full Text] [Related]

  • 14. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
    Siemann DW, Morrissey S, Wolf K.
    Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW, Maddison K, Wolf K, Hill SA, Keng PC.
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [Abstract] [Full Text] [Related]

  • 19. Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU.
    Lee FY, Workman P.
    Br J Cancer; 1985 Jan; 51(1):85-91. PubMed ID: 3966974
    [Abstract] [Full Text] [Related]

  • 20. Chemopotentiation of CCNU metabolites by misonidazole.
    Mulcahy RT.
    Br J Cancer; 1985 May; 51(5):733-5. PubMed ID: 3994915
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.